MCET — Multicell Technologies Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Multicell Technologies, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

	2010 November 30th	C2011 November 30th	2012 November 30th	2013 November 30th	2014 November 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.099	0.049	0.049	0.049	0.049
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1.87	2.2	1.49	1.42	0.56
Operating Profit	-1.78	-2.15	-1.44	-1.37	-0.511
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1.29	-1.95	-1.36	-1.37	-0.529
Provision for Income Taxes
Net Income After Taxes	-1.29	-1.95	-1.36	-1.37	-0.529
Minority Interest
Net Income Before Extraordinary Items
Net Income	-1.17	-1.8	-1.26	-1.23	-0.38
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-1.3	-1.8	-1.26	-1.23	-0.38
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.002	-0.003	-0.001	-0.001	-0
Dividends per Share